What is Amneal Pharmaceuticals, Inc.'s price / earnings?

Amneal Pharmaceuticals, Inc. (AMRX) reported price / earnings of 32.5× in Q1 2026.

What does price / earnings mean?

Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

Amneal Pharmaceuticals, Inc. AMRX Price / earnings

Price / earnings at other companies

PfizerPFE

14.7×—

Cardinal HealthCAH

32×+10.6×

McKessonMCK

22.3×-3.3×

CencoraCOR

29.9×+6.0×

Jazz PharmaceuticalsJAZZ

15.6×-7.1×

AbbVieABBV

105.8×+17.5×

Other financials

Income statement

See full

Revenue$722.5M+3.9%

Gross profit$320.1M+25.1%

Operating income$141.8M+41.3%

Net income$62.3M+411%

EPS (diluted)$0.19+375%

Balance sheet

See full

Cash & equivalents$197.7M+234%

Total debt$2.6B+17.7%

Total equity-$45.4M+65.5%

Total assets$3.5B+5.2%

Cash flow

See full

Operating cash flow-$26.7M-461%

CapEx$8.2M-37.9%

Free cash flow-$34.9M-507%

Valuation

See full

Market cap$5.17B+51.0%

Profitability

See full

Gross margin38.7%+2.0pp

Operating margin14.3%+1.6pp

Net margin4%+3.6pp

FCF margin7.9%-1.0pp

Returns & leverage

See full

Return on equity-52.8%-12.7pp

Debt / equity127.9×+119×

Current ratio2.5×+1.1×

Where this comes from

Calculated from Amneal Pharmaceuticals, Inc.’s reported figures.

market cap/net income=32.5×

Based on the most recent quarter.

The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amneal Pharmaceuticals, Inc.'s price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amneal Pharmaceuticals, Inc.'s price / earnings?: Amneal Pharmaceuticals, Inc. (AMRX) reported price / earnings of 32.5× in Q1 2026.
What does price / earnings mean?: Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.